NCT06638060

Brief Summary

To confirm feasibility and accessibility of the CCPC Platform (Oxymotion, Bridge Health Solutions medication adherence software, CloudDX home kit) in two different environments - 1) hospital (Acute Care for Elderly Unit) and 2) at-home .

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
2mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Mar 2025Jun 2026

First Submitted

Initial submission to the registry

September 16, 2024

Completed
29 days until next milestone

First Posted

Study publicly available on registry

October 15, 2024

Completed
5 months until next milestone

Study Start

First participant enrolled

March 13, 2025

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2026

Last Updated

March 12, 2026

Status Verified

May 1, 2025

Enrollment Period

1.3 years

First QC Date

September 16, 2024

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (6)

  • Collect patient and clinicians' feedback about the CCPC Platform

    This will be completed via an assessment of the quantitative data on how long and how often patients use this monitoring and what were the reasons that patients took the monitors on and off.

    From enrollment to the end of follow up at 10 days

  • Collect patient and clinicians' feedback about the CCPC Platform

    This will be completed via an assessment of the Usability Questionnaire.

    From enrollment to the end of follow up at 10 days

  • Collect patient and clinicians' feedback about the CCPC Platform

    This will be completed by an evaluation for potential harm, e.g. anxiety questionnaire and any patient-reported adverse events.

    From enrollment to the end of follow up at 10 days

  • Confirm the technical goals of the CCPC platform are met.

    This will be completed by ensuring clinician workflow is met, via feedback sessions (e.g. conversations, questionnaires).

    From enrollment to the end of follow up at 10 days

  • Confirm the technical goals of the CCPC platform are met.

    This will be completed via an assessment of the data flow: does the correct patient data reach the clinicians at the right time?

    From enrollment to the end of follow up at 10 days

  • Confirm the technical goals of the CCPC platform are met.

    This will be completed by determining if the CCPC platform provided a holistic view of each patient with vitals, medication, labs and other collected data.

    From enrollment to the end of follow up at 10 days

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

The Acute Care for Elderly Unit at SPH for 40 inpatients over the age of 65.

You may qualify if:

  • Inpatients on the Acute care of the Elderly ward.

You may not qualify if:

  • Lack of capacity to consent to the study including moderate-severe dementia or delirium
  • Unable to use (or does not have a caregiver who can help put on) study monitoring device at home
  • Unable to complete (or does not have a caregiver who can help complete) study questionnaires by electronic (mobile, tablet, or computer), paper, nor phone
  • Patient with known allergic reactions to any part material of the device
  • People under 40kg

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

St. Paul'sHospital

Vancouver, British Columbia, V6Z 1Y6, Canada

RECRUITING

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2024

First Posted

October 15, 2024

Study Start

March 13, 2025

Primary Completion (Estimated)

June 21, 2026

Study Completion (Estimated)

June 21, 2026

Last Updated

March 12, 2026

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations